Skip to main content

Table 5 Improvement in NEI-VFQ 25 and other measures in nAMD patients after 3 months of intravitreal anti-VEGF treatment

From: Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population

Variables

Baseline

3 months

P-value of baseline-3 months

NEI-VFQ 25 score

79.53 (14.52)

82.20 (13.68)

< 0.001

EQ-5D score

0.74 (0.28)

0.70 (0.32)

0.64

PASS 5

3.29 (0.80)

2.82 (0.80)

< 0.001

LogMar best eye

0.19 (0.03)

0.15 (0.22)

0.015

LogMar treated eye

0.59 (0.49)

0.44 (0.42)

< 0.001

  1. Bold values = P < 0.001 P < 0.05